KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers

Oncotarget

Volumn 6, Issue 5, 2015, Pages 3240-3253

  Lee, Kyung Hwa ^a   Ahn, Eun Jung ^a   Oh, Se Jeong ^a   Kim, Ok ^a   Joo, Young Eun ^a   Bae, Jeong A ^b   Yoon, Somy ^b   Ryu, Hyang Hwa ^a   Jung, Shin ^a   Kim, Kyung Keun ^b   Lee, Jae Hyuk ^a   Moon, Kyung Sub ^a  

^a Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Epithelial mesenchymal transition; Glioma; Human VANGL1 protein; Neoplasm invasiveness; Neoplastic stem cell

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD133 ANTIGEN; KAI1 COOH TERMINAL INTERACTING TETRASPANIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PROTEIN EPH B1; PROTEIN ZEB2; TETRASPANIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; MEMBRANE PROTEIN; VANGL1 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STEMNESS; CANCER SURVIVAL; CARCINOGENESIS; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL; SURVIVAL TIME; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BRAIN NEOPLASMS; C57BL MOUSE; CANCER STEM CELL; CELL MOTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE;

ANIMALS; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GLIOMA; HUMANS; MALE; MEMBRANE PROTEINS; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84923286238     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3087     Document Type: Article

References (52)

1. Kleihues P, Louis DN, Wiestler OD, Burger PC and Scheithauer BW. (2007). WHO grading of tumours of the central nervous system In: Bosman FT, Jaffe ES, Lakhani SR and Ohgaki H, eds. WHO classification of tumours of the central nervous system. (Lyon: International Agency for Research on Cancer).
2. Siebzehnrubl FA, Reynolds BA, Vescovi A, Steindler DA and Deleyrolle LP. The origins of glioma: E Pluribus Unum? Glia. 2011; 59(8):1135-1147.
3. Reya T, Morrison SJ, Clarke MF and Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859):105-111.
4. Cheng L, Wu Q, Guryanova OA, Huang Z, Huang Q, Rich JN and Bao S. Elevated invasive potential of glioblastoma stem cells. Biochem Biophys Res Commun. 2011; 406(4):643-648.
5. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756- 760.
6. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-996.
7. Boyer B, Valles AM and Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol. 2000; 60(8):1091-1099.
8. Singh A and Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010; 29(34):4741-4751.
9. Utsuki S, Sato Y, Oka H, Tsuchiya B, Suzuki S and Fujii K. Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol. 2002; 57(3):187-192.
10. Howng SL, Wu CH, Cheng TS, Sy WD, Lin PC, Wang C and Hong YR. Differential expression of Wnt genes, betacatenin and E-cadherin in human brain tumors. Cancer Lett. 2002; 183(1):95-101.
11. Asano K, Duntsch CD, Zhou Q, Weimar JD, Bordelon D, Robertson JH and Pourmotabbed T. Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J Neurooncol. 2004; 70(1):3-15.
12. Lewis-Tuffin LJ, Rodriguez F, Giannini C, Scheithauer B, Necela BM, Sarkaria JN and Anastasiadis PZ. Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS one. 2010; 5(10):e13665.
13. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 1995; 268(5212):884-886.
14. Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M and Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res. 1996; 56(8):1751-1755.
15. Huang CI, Kohno N, Ogawa E, Adachi M, Taki T and Miyake M. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol. 1998; 153(3):973-983.
16. Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H, Satoh S, Kobayashi N, Yamaoka Y and Miyake M. Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer. 2003; 89(1):158- 167.
17. Lee JH, Seo YW, Park SR, Kim YJ and Kim KK. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res. 2003; 63(21):7247-7255.
18. Yagyu R, Hamamoto R, Furukawa Y, Okabe H, Yamamura T and Nakamura Y. Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. Int J Oncol. 2002; 20(6):1173- 1178.
19. Lee JH, Park SR, Chay KO, Seo YW, Kook H, Ahn KY, Kim YJ and Kim KK. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res. 2004; 64(12):4235-4243.
20. Lee JH, Cho ES, Kim MY, Seo YW, Kho DH, Chung IJ, Kook H, Kim NS, Ahn KY and Kim KK. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein. Cancer Res. 2005; 65(19):8993-9003.
21. Kho DH, Bae JA, Lee JH, Cho HJ, Cho SH, Lee JH, Seo YW, Ahn KY, Chung IJ and Kim KK. KITENIN recruits Dishevelled/PKC delta to form a functional complex and controls the migration and invasiveness of colorectal cancer cells. Gut. 2009; 58(4):509-519.
22. Lee JK, Lim SC, Kim HD, Yoon TM, Kim K, Nam JH, Kim HS, Shin MH and Kim KK. KITENIN represents a more aggressive phenotype in a murine model of oral cavity squamous carcinoma. Otolaryngol Head Neck Surg. 2010; 142(5):747-752 e741-742.
23. Bae JA, Yoon S, Park SY, Lee JH, Hwang JE, Kim H, Seo YW, Cha YJ, Hong SP, Kim H, Chung IJ and Kim KK. An Unconventional KITENIN/ErbB4-Mediated Downstream Signal of EGF Upregulates c-Jun and the Invasiveness of Colorectal Cancer Cells. Clin Cancer Res. 2014; 20(15):4115-4128.
24. Park SY, Kim H, Yoon S, Bae JA, Choi SY, Jung YD and Kim KK. KITENIN-targeting MicroRNA-124 Suppresses Colorectal Cancer Cell Motility and Tumorigenesis. Mol Ther. 2014; 22(9):1653-1664
25. Cheng WY, Kandel JJ, Yamashiro DJ, Canoll P and Anastassiou D. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PLoS One. 2012; 7(4):e34705.
26. Kahlert UD, Maciaczyk D, Doostkam S, Orr BA, Simons B, Bogiel T, Reithmeier T, Prinz M, Schubert J, Niedermann G, Brabletz T, Eberhart CG, Nikkhah G and Maciaczyk J. Activation of canonical WNT/beta-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-tomesenchymal transition. Cancer Lett. 2012; 325(1):42-53.
27. Kim YW, Koul D, Kim SH, Lucio-Eterovic AK, Freire PR, Yao J, Wang J, Almeida JS, Aldape K and Yung WK. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis. Neuro Oncol. 2013; 15(7):829-839.
28. Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M and Bergers G. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/ VEGFR2 complex. Cancer Cell. 2012; 22(1):21-35.
29. Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H, Gonzalez-Herrero I, Sanchez-Garcia I, Silber JR, Horner PJ and Rostomily RC. TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer. 2010; 9:194.
30. Yang HW, Menon LG, Black PM, Carroll RS and Johnson MD. SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer. 2010; 10:301.
31. Qi S, Song Y, Peng Y, Wang H, Long H, Yu X, Li Z, Fang L, Wu A, Luo W, Zhen Y, Zhou Y, Chen Y, Mai C, Liu Z and Fang W. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma. PLoS One. 2012; 7(6):e38842.
32. Lee S, Song YA, Park YL, Cho SB, Lee WS, Lee JH, Chung IJ, Kim KK, Rew JS and Joo YE. Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression. Pathol Int. 2011; 61(4):210-220.
33. Yoon TM, Kim SA, Lee JK, Park YL, Kim GY, Joo YE, Lee JH, Kim KK and Lim SC. Expression of KITENIN and its association with tumor progression in oral squamous cell carcinoma. Auris Nasus Larynx. 2013; 40(2):222-226.
34. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1):98-110.
35. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG and Aldape K. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006; 9(3):157-173.
36. Yan YR, Xie Q, Li F, Zhang Y, Ma JW, Xie SM, Li HY and Zhong XY. Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells. Neuropathology. 2014; 34(2):128-134.
37. Mahabir R, Tanino M, Elmansuri A, Wang L, Kimura T, Itoh T, Ohba Y, Nishihara H, Shirato H, Tsuda M and Tanaka S. Sustained elevation of Snail promotes glialmesenchymal transition after irradiation in malignant glioma. Neuro Oncol. 2014; 16(5):671-685.
38. Meng J, Li P, Zhang Q, Yang Z and Fu S. A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway. Oncotarget. 2014; 5(13):4683-4693.
39. Rao SA, Srinivasan S, Patric IR, Hegde AS, Chandramouli BA, Arimappamagan A, Santosh V, Kondaiah P, Rao MR and Somasundaram K. A 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma. PLoS One. 2014; 9(1):e85200.
40. Zarkoob H, Taube JH, Singh SK, Mani SA and Kohandel M. Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein. PLoS One. 2013; 8(5):e64169.
41. Sailer MH, Gerber A, Tostado C, Hutter G, Cordier D, Mariani L and Ritz MF. Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling. J Cell Sci. 2013; 126(Pt 16):3533-3540.
42. Velpula KK, Dasari VR, Tsung AJ, Dinh DH and Rao JS. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1. Oncotarget. 2011; 2(12):1028-1042.
43. Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, Devers KG, Yachnis AT, Kupper MD, Neal D, Nabilsi NH, Kladde MP, Suslov O, Brabletz S, Brabletz T, Reynolds BA, et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med. 2013; 5(8):1196-1212.
44. Elsum IA, Martin C and Humbert PO. Scribble regulates an EMT polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation. J Cell Sci. 2013; 126(Pt 17):3990-3999.
45. Hong J, Zhou J, Fu J, He T, Qin J, Wang L, Liao L and Xu J. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res. 2011; 71(11):3980-3990.
46. Yang F, Nam S, Brown CE, Zhao R, Starr R, Ma Y, Xie J, Horne DA, Malkas LH, Jove R and Hickey RJ. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling. PLoS One. 2014; 9(4):e94443.
47. Yoon CH, Kim MJ, Kim RK, Lim EJ, Choi KS, An S, Hwang SG, Kang SG, Suh Y, Park MJ and Lee SJ. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells. Oncogene. 2012; 31(44):4655-4666.
48. Cui J, Han SY, Wang C, Su W, Harshyne L, Holgado- Madruga M and Wong AJ. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Cancer Res. 2006; 66(20):10024-10031.
49. Li JY, Wang H, May S, Song X, Fueyo J, Fuller GN and Wang H. Constitutive activation of c-Jun N-terminal kinase correlates with histologic grade and EGFR expression in diffuse gliomas. J Neurooncol. 2008; 88(1):11-17.
50. Mao P, Joshi K, Li J, Kim SH, Li P, Santana-Santos L, Luthra S, Chandran UR, Benos PV, Smith L, Wang M, Hu B, Cheng SY, Sobol RW and Nakano I. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci U S A. 2013; 110(21):8644-8649.
51. Kim GE, Kim JH, Lee KH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Park MH and Yoon JH. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors. Appl Immunohistochem Mol. 2012; 20(3):298-303.
52. National Cancer Institute. REMBRANDT home page. 2014 [cited 2014 May 13]; Available from: https://caintegrator.nci.nih.gov/rembrandt/login.do.